To unequivocally exclude the possibility that the NRF2/KEAP1 axis is involved in the 4-OI-mediated increase of VSVΔ51 in cancer cells, KEAP1 was removed using a similar transient CRISPR/Cas9 gene editing strategy. This evidence concerns the gene KEAP1 and cancer.